Session Information
2009 BIO International Convention
Click here to go to the previous page
Biopharmaceutical Manufacturing Challenges - When Will Harmonization Resolve the Differences?
Track : Manufacturing of Biologics & Drugs
Program Code: 2730
Date: Tuesday, May 19, 2009
Time: 10:00 AM to 11:30 AM  EST
Location: B302
SPEAKER (S):
Lothar Hartmann, Roche
Brigitte Holst, Novo Nordisk, Inc
Simon Hotchin, Amgen
John O'Connor, PhD, Genentech, Inc
Description
Pharmaceuticals for global markets are frequently sourced from a single manufacturing site. The standards used for manufacturing quality are, however, applied variably between the major pharmaceutical regulatory regions of the US, EU and Japan. Differences in chemistry, manufacturing and control data requirements between the major regions will also be discussed with respect to their potential impact on manufacturing operations.

• Illustrate the differences in manufacturing standards around the world and raise awareness of the cost implications of applying different standards
• Provoke discussions on current best manufacturing practices
• Identify potential solutions to overcome the current situation


Audio Synchronized to PowerPoint
(Code: 2730)
  
This session is a part of: